-
Cello
Group plc (LON:CLL) is split into two distinct businesses - Cello
Health and Cello Signal. Cello Health delivers cutting-edge marketing
advisory services to the global pharmaceutical and health sectors. Cello
Signal delivers digitally-led insight and marketing support services to
global consumer and business-to-business clients.
Group chief executive Mark Scott told Proactive their push into the US is their big focus for 2017 as the firm looks to enlarge the presence of Cello Health across the pond.
“We have a good footprint of five offices, we're making a big effort to expand them and then Signal is energetically going into the US, adding to its US capabilities in the next year.
“So for example, Signal has an LA office which we're doubling in size, we're taking Pulsar - the social media analytics software to New York, we've already got around seven large clients for it, we've also managed to penetrate the US charity space pretty effectively and we're also very big in the US tech space,” Scott said.
http://www.4-traders.com/CELLO-GROUP-PLC-4004929/
www.cellogroup.com/
"#Clinical, #patient & #commercial value need to be considered collectively." Our newest article on EADC live now! https://t.co/k6NcfCUKvq pic.twitter.com/yGuZ0RK8aO— Cello Health (@cellohealth) October 5, 2016
US and EU regulators collaborate on #rarediseases https://t.co/pQ7dxXbHCl
— Cello Health (@cellohealth) September 29, 2016
No comments:
Post a Comment